AR126029A1 - LIGANDOS DE PÉPTIDOS BICÍCLICOS ESPECÍFICOS PARA EL RECEPTOR DE TRANSFERRINA 1 (TfR1) - Google Patents

LIGANDOS DE PÉPTIDOS BICÍCLICOS ESPECÍFICOS PARA EL RECEPTOR DE TRANSFERRINA 1 (TfR1)

Info

Publication number
AR126029A1
AR126029A1 ARP210103150A ARP210103150A AR126029A1 AR 126029 A1 AR126029 A1 AR 126029A1 AR P210103150 A ARP210103150 A AR P210103150A AR P210103150 A ARP210103150 A AR P210103150A AR 126029 A1 AR126029 A1 AR 126029A1
Authority
AR
Argentina
Prior art keywords
multimeric binding
tfr1
peptide
peptide ligands
peptide ligand
Prior art date
Application number
ARP210103150A
Other languages
English (en)
Spanish (es)
Inventor
Ellen Gowans
Gemma Elizabeth Mudd
Michael Rigby
Punit Seth
Michael Skynner
Steven STANWAY
Liudvikas Urbonas
Rietschoten Katerine Van
Original Assignee
Bicycletx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2017927.1A external-priority patent/GB202017927D0/en
Priority claimed from GBGB2106903.4A external-priority patent/GB202106903D0/en
Application filed by Bicycletx Ltd filed Critical Bicycletx Ltd
Publication of AR126029A1 publication Critical patent/AR126029A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ARP210103150A 2020-11-13 2021-11-12 LIGANDOS DE PÉPTIDOS BICÍCLICOS ESPECÍFICOS PARA EL RECEPTOR DE TRANSFERRINA 1 (TfR1) AR126029A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2017927.1A GB202017927D0 (en) 2020-11-13 2020-11-13 Bicyclic peptide ligands specific for transferrin
GBGB2106903.4A GB202106903D0 (en) 2021-05-14 2021-05-14 Bicycle peptide ligands specific for transferrin
US202163261820P 2021-09-29 2021-09-29

Publications (1)

Publication Number Publication Date
AR126029A1 true AR126029A1 (es) 2023-09-06

Family

ID=81600834

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210103150A AR126029A1 (es) 2020-11-13 2021-11-12 LIGANDOS DE PÉPTIDOS BICÍCLICOS ESPECÍFICOS PARA EL RECEPTOR DE TRANSFERRINA 1 (TfR1)

Country Status (13)

Country Link
US (3) US11970555B2 (cg-RX-API-DMAC7.html)
EP (1) EP4244235A1 (cg-RX-API-DMAC7.html)
JP (1) JP7848202B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230107589A (cg-RX-API-DMAC7.html)
CN (1) CN116802190A (cg-RX-API-DMAC7.html)
AR (1) AR126029A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021376917A1 (cg-RX-API-DMAC7.html)
CA (1) CA3201414A1 (cg-RX-API-DMAC7.html)
IL (1) IL302713A (cg-RX-API-DMAC7.html)
MX (1) MX2023005624A (cg-RX-API-DMAC7.html)
SA (1) SA523440745B1 (cg-RX-API-DMAC7.html)
TW (1) TWI921406B (cg-RX-API-DMAC7.html)
WO (1) WO2022101633A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116802190A (zh) 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体
GB202206431D0 (en) * 2022-05-03 2022-06-15 Bicycletx Ltd Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)
KR20260021596A (ko) * 2023-04-05 2026-02-13 아이오니스 파마수티컬즈, 인코포레이티드 Pln 발현을 감소시키는 화합물 및 방법
EP4788689A1 (en) 2023-10-03 2026-08-12 BicycleTx Limited Bicyclic peptide ligand complexes specific for tfr1
GB202316970D0 (en) * 2023-11-06 2023-12-20 Bicycletx Ltd Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
GB0914110D0 (en) 2009-08-12 2009-09-16 Medical Res Council Peptide libraries
CA2967830A1 (en) * 2014-11-14 2016-05-19 Ossianix, Inc. Tfr selective binding compounds and related methods
CN104650186A (zh) 2015-03-09 2015-05-27 中国药科大学 一种能够与TfR1特异性结合的活性肽及其应用
CA2990785C (en) * 2015-06-24 2024-11-12 Jcr Pharmaceuticals Co., Ltd. ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODIES CROSSING THE BLOOD-BRAIN BARRIER
GB201706477D0 (en) 2017-04-24 2017-06-07 Bicycle Therapeutics Ltd Modification of polypeptides
EP3615550A1 (en) 2017-04-27 2020-03-04 BicycleTx Limited Bicyclic peptide ligands and uses thereof
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CA3080351A1 (en) 2017-11-02 2019-05-09 Ossianix, Inc. Improved tfr-selective binding peptides capable of crossing the blood brain barrier
CA3091775A1 (en) * 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
WO2020084305A1 (en) 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof
EP3897849A1 (en) * 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201912320D0 (en) * 2019-08-28 2019-10-09 Bicycletx Ltd PBP Binding Bicyclic Peptide Ligands
CN116802190A (zh) 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体

Also Published As

Publication number Publication date
KR20230107589A (ko) 2023-07-17
JP2023549229A (ja) 2023-11-22
IL302713A (en) 2023-07-01
AU2021376917A1 (en) 2023-06-29
AU2021376917A9 (en) 2024-09-12
CA3201414A1 (en) 2022-05-19
US20240391959A1 (en) 2024-11-28
MX2023005624A (es) 2023-05-24
TWI921406B (zh) 2026-04-11
WO2022101633A1 (en) 2022-05-19
US20220194988A1 (en) 2022-06-23
EP4244235A1 (en) 2023-09-20
SA523440745B1 (ar) 2024-07-24
JP7848202B2 (ja) 2026-04-20
TW202233664A (zh) 2022-09-01
US20250340595A1 (en) 2025-11-06
US11970555B2 (en) 2024-04-30
CN116802190A (zh) 2023-09-22

Similar Documents

Publication Publication Date Title
MX2020013784A (es) Ligandos de peptidos biciclicos especificos para nectina-4.
HRP20250841T1 (hr) Heterotandemski biciklični peptidni kompleksi
MX2021013669A (es) Ligandos peptidicos biciclicos especificos para ox40.
JP2022542386A5 (cg-RX-API-DMAC7.html)
MX2020006474A (es) Ligandos de peptidos biciclicos especificos para el receptor eph de tirosina quinasa a2 (epha2).
SA520420008B1 (ar) جزيئات ترابطية ببتيدية ثنائية الحلقات متعددة الوحدات
Ramadori et al. Platelets in chronic liver disease, from bench to bedside
JP2022512478A5 (cg-RX-API-DMAC7.html)
JP2022544058A5 (cg-RX-API-DMAC7.html)
AR064555A1 (es) Peptido wt1 restringido a hla-a*1101 y composicion farmaceutica que comprende el mismo
FI3511004T3 (fi) Yhdistelmävalmisteita syövän hoitoon
CA2961029A1 (en) Peptidomimetic macrocycles and formulations thereof
JP2022513223A5 (cg-RX-API-DMAC7.html)
US10039807B2 (en) bFGF-polymer conjugates, methods for making the same and applications thereof
HRP20160020T1 (hr) Postupak za aktiviranje pomagaäśke t stanice i pripravak za uporabu u postupku
MX2023005624A (es) Ligandos peptidicos biciclicos especificos para el receptor de transferrina 1 (tfr1).
EA202192555A1 (ru) Комбинированная терапия для лечения рака
MX2026000307A (es) Ligando de proteina para la activacion de fibroblastos y su uso
ES2321114T3 (es) Camptotecinas conjugadas en posicion 7 con peptidos ciclicos como agentes citostacios.
AU2015235978B2 (en) Cyclic prosaposin peptides and uses thereof
JP2018526987A5 (cg-RX-API-DMAC7.html)
AR115601A1 (es) Ligandos peptídicos bicíclicos específicos para nectina-4
TW202216204A (zh) Vegf結合肽
EA202190104A1 (ru) Бициклические пептидные лиганды, специфичные к нектину-4
TH2001007117A (th) ลิแกนด์ เปปไทด์ ไบไซคลิกที่จำเพาะสำหรับเนคทิน-4